Bookmark and Share
UNII-2S42T2808B (CID 3000709) - Compound BioActivity Data
.
BioActivity Outcomes:
Active(1)
 
 
Unspecified(9)
 
 
Top Targets:
DHFR(1)
 
 
BioAssay Types:
Literature(10)
 
 
 
BioActivity Types:
IC50(4)
 
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 10    Data Row: 10   Total Pages: 1   
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID103229694]
IC50 10Inhibitory activity against beta-lactamase [AID218575, Type: Literature]
View
2
[SID103229694]
IC50 50Inhibitory activity against chymotrypsinogen [AID52780, Type: Literature]
View
3
[SID103229694]
IC50 60Inhibitory activity against cloned Dihydrofolate reductase (cDHFR) [AID56466, Type: Literature]Dihydrofolate reductase [gi:118985]
View
4
[SID103229694]
IC50 300Inhibition of Beta-galactosidase [AID40277, Type: Literature]
View
5
[SID103229694]
Effect of BSA on Chymotrypsinogen inhibition by the compound, expressed as fold increase in IC50 [AID52789, Type: Literature]
View
6
[SID103229694]
Preincubated with beta-lactamase, inhibitory activity expressed as fold decrease in IC50(ie. improved activity) [AID218566, Type: Literature]
View
7
[SID103229694]
Effect of BSA on Beta-lactamase inhibition by the compound, expressed as fold increase in IC50 [AID218685, Type: Literature]
View
8
[SID103229694]
Effect of Guanidinium (GndHcl) on beta-lactamase inhibition by the compound, expressed as fold increase in IC50 [AID218687, Type: Literature]
View
9
[SID103229694]
Effect of Urea on beta-lactamase inhibition by the compound, expressed as fold increase in IC50 [AID218688, Type: Literature]
View
10
[SID103229694]
The effect of 10-fold increase in enzyme concentration on beta-lactamase inhibition. [AID218689, Type: Literature]
View